Personalizing medicine through targeted agents, capitalizing on pathway dysregulation and biomarker use

ISSN： 1741-0541

Source： Personalized Medicine, Vol.5, Iss.6, 2008-11, pp. : 575-577

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lung Cancer Mutations and Use of Targeted Agents in Hispanics

Reviews on Recent Clinical Trials, Vol. 9, Iss. 4, 2014-01 ,pp. : 225-232

Bentham Science Publishers

Access to resources Recommend Favorite

Metabolomics as a tool for personalizing medicine: 2012 update

By Sun Jinchun Beger Richard D Schnackenberg Laura K

Personalized Medicine, Vol. 10, Iss. 2, 2013-03 ,pp. : 149-161

Future Medicine

Access to resources Recommend Favorite

Optimal Use of Targeted Agents for Advanced Gastrointestinal Stromal Tumours

Oncology, Vol. 78, Iss. 2, 2010-04 ,pp. : 130-140

Karger

Access to resources Recommend Favorite

MODIFICATION OF ANXIETY THROUGH THE USE OF HYPNOSIS IN PHYSICAL MEDICINE*

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 11, Iss. 3, 1963-03 ,pp. : 235-237

John Wiley & Sons Inc

Access to resources Recommend Favorite

Crowdsourced science and genetic insights for personalizing medicine: beginning to deliver the goods

By Torr-Brown Sheryl

Personalized Medicine, Vol. 9, Iss. 6, 2012-08 ,pp. : 569-572

Future Medicine

Access to resources Recommend Favorite